BioCircuit

Health Care · Health & Medical Electronics
Sponsors visas1 public contract won
Lately:$350k won in the last 12 months11 news stories in 90 daysFollow changes →

Facts

as of Nov 20, 2026

BioCircuit Technologies is at the forefront of developing and commercializing advanced medical devices for tissue repair and neuromodulation. Our first commercial product, Nerve Tape®, is the first sutureless device for repairing transected nerves.

Legal name
BioCircuit Technologies, Inc.
Headquarters
Atlanta, United States
Founded
2016
Employees
51-200estimated range
Register numbers
EIN 812248893
Official records
SEC CIK 1777259

These are the key facts about BioCircuit on Alion as of Nov 20, 2026. BioCircuit is headquartered in Atlanta, United States. It was founded in 2016. It has raised $13.7M in 3 funding rounds. The latest round is Convertible Note of $9M, announced in 2022.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
BioCircuit Technologies, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Named in the work visa registers of United States.

0H-1B filings in 12 months
0Open roles in United States

In the register as BioCircuit Technologies, Inc., Atlanta, GA

Other sponsors in the same field
Alert me
US Department of Labor · latest filing May 5, 2025 · the register ↗

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Atlanta United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$13.7MTotal raised
$10MPublic grants5 public grants
GrantLatest round
8Rounds and grants
Money by yearUSD, rounds and grants
2024$2.1M1 record
2023$6M3 records
2022$9M1 record
2021$3.2M1 record
2020$1.9M1 record
2019$1.5M1 record
Largest rounds and grants
2024
$2.1M
2023
$2.1M
2023
$2.1M
Sources: funding announcements, grant and company registers

Money

BioCircuit has $13.7M paid in by investors, lenders and donors.

$13.7MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Grant
Sep 2024 · Grant
$2.1MPaid
Grant
Sep 2023 · Grant
$1.8MPaid
Grant
Sep 2023 · Grant
$2.1MPaid
Grant
Apr 2023 · Grant
$2.1MPaid
Equity raised
Sep 2022 · Convertible note
$9MPaid
Equity raised
Apr 2021 · Convertible note
$3.2MPaid
Grant
Sep 2020 · Grant
$1.9MPaid
Equity raised
May 2019 · Venture round
$1.5MPaid
Taxes
No public tax figures for this company or its entities.
People cost

BioCircuit filed a median H-1B wage of $313k in 2025.

$313kMedian H-1B wage, 20251 casesSource ↗
Median H-1B wage by role, 2025scale to $313k
Chief Operating Officer · 1$313k
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

1 public contract won, $350k in all. $350k of it in the last 12 months.

1Contracts
$350kValue
$350kIn 12 months
1Buyer countries
Biggest buyers
Defense Advanced Research Projects Agency
United States · 1 public contract
$350k
Latest awards
Defense Advanced Research Projects Agency, United States · 2026-01
$350k
Sources: USAspending federal contract awards - award notices naming the company's legal entities as the winner

Public record

BioCircuit in public registers.

Influence
Employees' political contributions, 2026 cycle
89 contributions · their own money, not the company's; names not shown · fec.gov ↗
$4.4k
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.

Milestones

Sep 17, 2024
Won a grant $2.1M · CORDIS
Sep 29, 2023
Won a grant $1.8M · CORDIS
Oct 3, 2022
2016
Founded
Each milestone is dated by its source: registers, filings, the press

Newsroom

Oct 282026
News · International Business Times
Axogen shares rose nearly 22% after the nerve repair company exceeded third-quarter earnings and revenue expectations, raised its 2026 sales forecast and reported progress on ins…
Oct 22026
News · Quiver Quantitative
Axogen acquires BioCircuit Technologies, enhancing its surgical solutions with NerveTape, a sutureless nerve repair device.Quiver AI SummaryAxogen, Inc. announced the completion…
Sources: the outlets named on each headline, each story once